07:03 AM EDT, 05/05/2025 (MT Newswires) -- Integra LifeSciences Holdings ( IART ) reported Q1 adjusted earnings Monday of $0.41 per diluted share, down from $0.55 a year earlier.

Analysts surveyed by FactSet expected $0.43.

Net revenue for the quarter ended March 31 was $382.7 million, compared with $368.9 million a year earlier.

Analysts polled by FactSet expected $381.2 million.

The company expects Q2 adjusted EPS of $0.40 to $0.45 and revenue of $390 million to $400 million. Analysts polled by FactSet expect $417.1 million in revenue.

Integra LifeSciences ( IART ) cut its 2025 adjusted EPS guidance to between $2.19 and $2.29, from the previous range of $2.41 to $2.51, and reiterated its revenue of between $1.65 billion and $1.72 billion. Analysts polled by FactSet expect $1.68 billion in revenue.

Shares of Integra LifeSciences Holdings ( IART ) were down more than 4% in recent premarket activity Monday